Steroidogenesis in castration-resistant prostate cancer

M Shiota, S Endo, L Blas, N Fujimoto, M Eto - Urologic Oncology: Seminars …, 2023 - Elsevier
Castration resistance is in part attributable to aberrant activation of androgen receptor (AR)
signaling by the intracrine activation of androgen precursors derived from adrenal glands …
被引用次数：7 相关文章

Steroidogenesis in castration-resistant prostate cancer

M Shiota, S Endo, L Blas… - Urologic Oncology …, 2023 - kyushu-u.elsevierpure.com
Castration resistance is in part attributable to aberrant activation of androgen receptor (AR)
signaling by the intracrine activation of androgen precursors derived from adrenal glands …

[引用][C] Steroidogenesis in castration-resistant prostate cancer

M Shiota, S Endo, L Blas, N Fujimoto… - … Oncology: Seminars and …, 2023 - cir.nii.ac.jp
Steroidogenesis in castration-resistant prostate cancer | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Steroidogenesis in castration-resistant prostate cancer

M Shiota, S Endo, L Blas, N Fujimoto… - Urologic …, 2023 - pubmed.ncbi.nlm.nih.gov
Castration resistance is in part attributable to aberrant activation of androgen receptor (AR)
signaling by the intracrine activation of androgen precursors derived from adrenal glands …

Steroidogenesis in castration-resistant prostate cancer.

M Shiota, S Endo, L Blas, N Fujimoto, M Eto - Urologic Oncology, 2022 - europepmc.org
Castration resistance is in part attributable to aberrant activation of androgen receptor (AR)
signaling by the intracrine activation of androgen precursors derived from adrenal glands …